Northwest Biotherapeutics reported 9.27M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 290.48M 41.49M
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
AstraZeneca AZN:LN 22.65B 3.6B
Bristol Myers Squibb BMY:US $ 30121M 3141M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Cti Biopharma CTIC:US $ 103.28M 34.9M
Cytori Therapeutics CYTX:US $ 22.1M 2.38M
Cytrx CYTR:US 6.18M 2.1M
Eisai 4523:JP Y 640606M 53549M
Genocea Biosciences GNCA:US $ 24.41M 17.41M
Infinity Pharmaceuticals INFI:US $ 70.1M 12.17M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Northwest Biotherapeutics NWBO:US 9.27M 8.02M
Pfizer PFE:US $ 54420M 5273M